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Alternative bone regeneration strategies that do not rely on harvested tissue or exogenous 
growth factors and cells are badly needed. However, creating living tissue constructs that 
are structurally, functionally and mechanically comparable to the natural bone has been a 
challenge so far. A major hurdle has been recreating the bone tissue microenvironment 
using the appropriate combination of cells, scaffold and stimulation to direct 
differentiation. This project presents a bone regeneration formulation that involves the use 
of human adipose-derived mesenchymal stems cells (hASCs) and a 3D scaffold based on 
a self-assembled peptide hydrogel doped with superparamagnetic nanoparticles (NPs). 
Osteogenic differentiation of hASCs is achieved through the direct stimulation by 
extremely-low frequency pulsed electromagnetic fields (pEMFs) and the indirect 
mechanical stimulation, through NP vibration induced by the field. This 3D construct was 
cultured for up to 21 days and its osteogenic capacity was assessed. Cellular morphology, 
proliferation, viability, as well alkaline phosphatase activity, calcium deposition were 
monitored during this time.  
 
The results show that the pEMFs have no negative effect on cell viability and 
induce early differentiation of hASCs to an osteoblastic phenotype when compared to a 
iv 
 
cell without biophysical stimulation. This effect results from the synergy between 
the pEMF and NP that acts as remote stimulation of the mechanotransduction pathways 
which activate biochemical signals between cells to go under differentiation or 
proliferation. The use of this approach offers a safe and effective treatment option for the 
treatment of non-union bone fractures. In addition, this formulation can be directly injected 
into the wound site, making it minimally invasive as well.
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1.1 Project overview  
Bone fractures represent a substantial incidence and cost burden among 
musculoskeletal injuries in the United States, with 15.3 million cases reported each year, 
of which 5-10% involve complications, such as delayed or non-unions (Nauth, et al., 2011). 
Conventional surgical treatments for bone damaged that resulted from trauma, tumor, bone 
fracture and abnormalities when the defect is above the critical size of 1-mm by either 
using autografts, allografts or metallic or ceramic implants (Meng et al., 2010).  Each of 
these bone grafts has some limitations, such as donor site morbidity, the risk of infections, 
pain, shortage in graft quantity and pathogen transmission (Brydone, et al., 2010; Meng, et 
al., 2010). Thus, recently, extensive efforts have been done to enhance bone tissue 
engineering to mimic the bone tissue microenvironment focusing on scaffolds as 
substitutes autologous or allogeneic bone grafts (Xu, et al., 2014) 
Bone tissue engineering and regenerative medicine required three complementary and 
essential components to mimic the native tissue through culturing diverse cell types in 
three-dimensional (3D) microenvironments to generate a fully functional tissue. These 
components are osteoprogenitor cells that responsible for creating bone tissue, biomimetic 
scaffold to provide 3D structure that is osteoconductive, and stimulation which can be 




 promoting cell differentiation (Horii, et al., 2007; Stevens, 2008; Neves, et al., 2017). To 
generate this microenvironment requires that the scaffold is manufactured in a way that 
mimics the nanostructure of the natural extracellular matrix (ECM; Li, et al., 2013). The 
ECM is considered a vital component of any tissue, which works not only supporting cells 
but also by creating an appropriate microenvironment that influences cell-function (Horii, 
et al., 2007). Therefore, by using a biomimetic scaffold that has similar properties as 
natural tissue ECM seeded with suitable cell types under the presence of appropriate 
stimulation can guide tissue growth and regeneration. 
However, creating living tissue constructs that are structurally, functionally and 
mechanically comparable to the natural bone has been a challenge (Polo-Corrales, et al., 
2014). For instance, recreating the bone tissue microenvironment using the appropriate 
combination of cells, scaffold and stimulation to direct differentiation (Polo-Corrales, et 
al., 2018). As an alternative, the use of extremely-low-frequency pulsed electromagnetic 
fields (pEMFs) as an adjuvant therapy for the treatment of bone disorders to reduce 
complications have been widely used in orthopedics since it was approved by the FDA 
almost four decades ago (Lohmann, et al., 2000). This allowed various clinical trials and 
production of commercial devices to promote bone fracture healing (Heckman, et al., 
1981). Since then, different effects of pEMF stimulation on in vitro differentiation and 
proliferation of osteogenic cell lines have been published in the literature (Daish, et al., 
2018). Researchers have indicated that the forced vibration of all the free ions on the 
surface of a cellular plasma membrane, changes in voltage, and conductivities are possible 
mechanisms in which EMF could regulate cell process (Panagopoulos, et al., 2002; 




have focused on the use of this therapy to accelerate the cell proliferation and osteogenic 
differentiation of progenitor cells, such as mesenchymal stem cells (MSCs).  
 
A strategy to improve fracture healing is to look more closely at the bone tissue 
microenvironment, in which mechanical stimulation is an important part and is essential 
for bone health and homeostasis (Voog and Jones, 2010). The importance of this type of 
stimulation is because it mediates an adaptive remodeling response in the bone at the 
cellular level, through a process known as Wolff’s law (Lanyon, 1974; Lanyon and 
Baggott, 1976; Woo, et al., 1981). At the molecular level, the process by which cells 
transduce these force-induced signals into biochemical responses is known as 
mechanotransduction and it leads to variations in gene expression, cell function, 
morphology, and extracellular matrix (ECM) remodeling. Since the mechanisms involved 
during bone remodeling are the same as those found during fracture healing (McKibbin, 
1978), it is thus reasonable to consider mechanical stimulation as a therapeutic strategy to 
induce healing when a bone fracture is present. A recent alternative that has shown great 
interest is the use of scaffolds that can provide mechanical stimulation through vibrations 
induced on superparamagnetic scaffolds by external EMF (Zeng, et al., 2012; Meng, et al., 
2013; Xu and Gu, 2014; Grant, et al., 2015). In addition, the presence of superparamagnetic 
nanoparticles (NPs) could also affect the mechanical properties of the scaffolds, by 
enhancing the compressive strength and elastic modulus. The improved mechanical 
properties in 3D scaffolds, particularly elastic modulus values, have been proven to 
promote MSC osteogenic differentiation (Jegal, et al. 2011). Early work on this type of 
scaffold was focused on polymer-based nanocomposites loaded with magnetic particles for 




Recently, the use of these superparamagnetic scaffolds and EMFs, to promote bone 
formation has been proposed (Kanczler, et al., 2010; Sapir-Lekhovitser, et al., 2016). The 
interesting aspect of this approach is that it couples two separate stimuli on the cells, 
mechanical, through the vibratory movement of the scaffold where the cells are attached 
to, and magnetic, where the forced-vibration of all the free ions on the surface of the plasma 
membrane, changes in voltage, and conductivities affecting cell function (Panagopoulos, 
et al., 2002; Deng, et al., 2007; Garner, et al., 2007). 
In this research, we used a biomimetic scaffold made of the self-assembling peptide 
RADA16, which consist of regular repeats of alternating ionic hydrophilic and 
hydrophobic amino acids and self-assemble to form stable β-sheet structures in water. 
When exposed to physiological solutions they spontaneous assemble into a stable, 
macroscopic membranous matrix, composed of ordered filaments (~10 nm) forming pores 
5–200 nm in size (Wang, et al., 2008; Zhang, et al., 1993; Zhang, et al., 1995). the self-
assembled peptide is the spontaneous arrangements of amino acids that followed the state 
of thermodynamic equilibrium to get a well-defined structure with firm organizations 
through various noncovalent interactions to produce hierarchical structures. In spite the 
fact that these interactions are weak, but when they together it formed a firm and stable 
structure (Zhang, 2002). This type consists of an alternating amino acid (Arginine, Alanine, 
and Aspartic acid) that spontaneously assembling to produce microscopic and macroscopic 
matrices of interwoven nanofibers to form higher-order hydrogels scaffolds in the presence 
of monovalent cations (Zhang et al.,1995; Hauser et al., 2010; Zhao et al., 2006). Although 
these interactions are weak, together they form microscopic and macroscopic matrices of 




2002; Hauser et al., 2010; Zhao et al., 2006). Due to their nanometer scale, their network 
and biomechanical properties are comparable to the natural ECM, making them good 
candidates to generate biomimetic cell niches (Semino, 2008). In addition, their stiffness 
can be modulated with concentration. Studies have found that collagen I and RADA16 
hydrogels have similar mechanical properties with mean G’ modulus values in the 10–1000 
Pa range (Semino, 2008; Cunha, et al., 2011). The generation of superparamagnetic 
scaffolds involves either a dip-coating method of the scaffolds in aqueous ferrofluids 
comprising biocompatible and nontoxic superparamagnetic nanoparticles (NPs), allowing 
these to infiltrate to the scaffold, or using in situ method by mixing NPs during scaffold 
synthesis, reducing the number of processing steps and time. It is expected that the 
superparamagnetic NPs will chelate to the hydrogel matrix (Kantipuly, et al., 1990). In this 
manner, the resulting magnetic scaffolds are capable to take up seeded cells (Bañobre-
López, et al., 2011; Samba Sivudu, et al., 2009). Our focus on this study is on the use 
adipose-derived mesenchymal stem cells (hASCs) encapsulated with self-assembled 
peptides containing superparamagnetic iron oxide NPs and study their capacity to 
differentiate after being biochemically-stimulated with osteogenic induction media and/or 




The main goal of this research is to create biologically compatible superparamagnetic 
scaffolds suitable for hASC growth and differentiation by mimicking the bone 
microenvironment to provide a level of osteoconductive and osteoinductive properties 




• Synthesis of biomimetic hydrogels using based on self-assembled peptides 
combined with superparamagnetic iron oxide nanoparticles to create a 3D porous 
scaffold and evaluate its specific functional groups through FTIR analysis. 
• Encapsulate the hASCs within the scaffold and evaluate their viability and 
morphology within the scaffold through LDH analysis and F-actin staining.  
• Evaluate the hASCs differentiation under pEMF stimulation in vitro by monitoring 








2.1 Bone structure  
Bone is a vascularized, metabolically dynamic connective tissue that forms, along 
with cartilage, the skeletal system of the body. The main function of bone is to provide 
mechanical support and physiological protection. The mechanical support is necessary to 
provide protection to vital organs and offer a site for muscle attachment to control 
movement. While the physiological protection results from the providing of reservoirs for 
growth factors and minerals such as calcium, potassium, carbonate, magnesium, strontium, 
chloride and fluoride, phosphate to maintain blood hemostasis and a place for 
hematopoiesis to occur. Since bone is a heterogenic structure, these functions vary 
depending on its location. For example, the bone that is not exposed to loadings, such as in 
the skull and scapula have a dissimilar structure to long bones, which are exposed to applied 
external forces such as tension, compression, and bending (Rogel, et al., 2008). 
 
 
2.2 Bone anatomy 
The adult human skeleton, which consists of 213 bones, can be classified according 




(i.e., skull, scapula, sternum, ribs, or mainly the facial skeleton bones) and tubular bone. 
The latter can be further classified as long tubular bone (i.e., femur, tibia, humerus, 
clavicles, etc.), or short tubular bone as in the hand and feet (i.e., metacarpals, metatarsals, 
and phalanges) (Buck, et al., 2012). The anatomical structure of the tubular bone consists 
mainly of three different sections: diaphysis, metaphysis, and epiphysis. The diaphysis is 
located in the middle of the tubular bone and has the shape of the cylindrical hollow shaft, 
composed mainly of dense and hard cortical bone, which is filled by the hollow shaft, or 
medullary cavity, that contains bone marrow and fat. The metaphysis located between 
diaphysis and epiphysis, is cone-shaped and composed of a growth plate that calcifies with 
age. The epiphysis located at the end of the tubular bone, with rounded and wide sections, 
consists primarily a trabecular spongy meshwork filled with red marrow and covered from 
the exterior with a thin shell of the cortical bone (Clarke, et al., 2008; Buck, et al., 2012). 
In contrast, flat bones have a varied structure consisting of either purely cortical bone or 
cortical bone with a thin central trabecular region. 
 
At the macrostructure level, cortical and trabecular are the primary bone structures 
that formed from the same matrix composition but vary in their porosity, 3D structure, and 
their metabolic activities. The cortical (also known as compact bone) makes up 80% of 
human body skeletal system, with a porosity of 5-10%, that has a compressive strength 
with the ability to resist torsion and bending. Although the trabecular (also known as 
cancellous bone) makes up only 20% of the body, with a 50-90% porosity of interconnected 
pores filled with bone marrow, which gives the ability of deformation and force absorption. 




bone has a higher metabolic activity (Buck, et al., 2012). In contrast, the cortical bone is 
covered by two surfaces, the outer surface called periosteal, which plays a role in the 
appositional growth and fracture healing. promoting bone enlargement through the process 
of periosteal apposition. The inner surface, called endosteal surface, has a high remodeling 
activity, allowing the bone to be under resorption (Clarke, et al., 2008; Datta et al., 2008). 
 
At the microstructure level, the main structure in cortical and trabecular bone 
consists of osteons (Figure 1). The osteons (also known as Haversian systems) in cortical 
bones are oriented longitudinally along long bones and consist of mineralized collagen 
fibers oriented in concentric layers. The osteons are approximately 200 µm in diameter and 
10-20 µm in length, with concentric lamellae 3–7 µm in diameter. It is also composed of a 
central Haversian canal which is a hollow tube, 80 µm in diameter, located in the center of 
the lamellae, allowing blood vessels to pass through it to distribute the necessary nutrients 
to bone cells (Athanasiou, et al., 2000; Rho, et al., 1998; Sharir, et al., 2008). Mineralized 
collagen fibers that are in a disorganized pattern, known as woven bone, yield a 
mechanically weak structure. When the lamellae are oriented tangentially to the external 
surface of the bone without making osteons and along with woven bone, they form a larger 
plywood-type stacking of dense layer known as a lamellar bone (Rho, et al., 1998).  
On the other hand, the trabecular osteons (also known as packets) have a semilunar 
shape formed from interconnected plates and rods with a thickness of 50-400 µm and with 
300-1500 µm of space between them (Athanasiou, et al., 2000; Clarke, et al., 2008). The 




stress. Consequently, trabecular bone is capable of enduring compressive stresses, an as a 
















Figure 1. Three-dimensional structure of bone that shows the cortical and trabecular 








2.3 Bone composition 
2.3.1 Bone Extracellular Matrix 
 
Bone is a compound that contains different materials that together constitute the 
bone matrix, which consists of about 90% of the total bone. The major components found 
in this 3D ECM are about 70% of inorganic components or minerals, 22% of organic 
components, mainly collagen, and about 8% lipids and water (Augat, et al., 2006; Buck, et 
al., 2012). The distribution of materials and their quality has a strong effect on bone 
strength; the composition of the mineral, which is mostly in the form of hydroxyapatite, 
gives the bone the ability to resist the compressive load and its quality affects bone 
stiffness. The collagen fibrils give the bone the ability to resist the tensile load and its 
quality affects bone toughness (Augat, et al., 2006; Athanasiou, et al., 2000). The 
mechanical properties of bone result from the interactions between these components, since 
the deposited mineral crystal and collagen are oriented in the longitudinal axis, giving bone 
its high stiffness and strength along its axis (Athanasiou, et al., 2000). The organic and 
inorganic components of the matrix interact together to produce a diverse set of mechanical 
and biological characteristics than those produce separately. Hence, the composition of the 
matrix plays a vital role in the calcified bone tissue whereas the elasticity is associated to 
the mineral phase of the bone and plasticity to the organic components of the matrix 
(Landis,1995).  
The organic component of mature bone that is considered its main building block. 
It consists mainly of the fibrous protein type I collagen that represents 90% of ECM 
proteins, which is organized in a fibrillar structure and sometimes onto which, the mineral 




of triple helical chains twisted around each other, consisting of two α1 polypeptide chains 
and one α2 chain. It structures composed of a sequence of three different amino acids 
glycine, proline and hydroxyproline that define the helix-forming repeated motif, which 
produces a rod shape molecule 1.4 nm wide and 300 nm long (Weiner, et al., 1998; Rogel, 
et al., 2008). During collagen synthesis, preprocollagen (i.e., a single chain of the 
polypeptide) becomes procollagen (i.e., a triple helix chain of the polypeptide) after 
hydroxylation and glycosylation, where hydrogen and disulfide bonds are formed. In 
addition, another bond is generated when tropocollagen (i.e., procollagen with a cut in the 
extra terminal amino acids) during which covalent bonds are formed between the terminal 
of the triple polypeptide helices (Last, et al., 1984; Zioupos, et al., 1999). The collagen 
fibril results from the self-assembling of tropocollagen by establishing a link to 
neighboring tropocollagen molecules through trivalent bonds known as 
hydroxypyridinium bonds (Zioupos, et al., 1999). The attachment between the NH2-
terminus of one triple helical molecule and the COOH-terminus of the following molecules 
forms a gap or a hole. This arrangement forms an area with densely packed molecules and 
an area of less densely packed molecules in the 2D model arrangement, while the 3D 
arrangement shows transverse channels or grooves (Weiner, et al., 1998). The mineralized 
collagen fibrils diameter is approximately 80-100 nm, and the mineral crystals between 
these fibrils are around 50 nm by 25 nm and 2–3 nm in thickness (Sharir, et al., 2008). In 
contrast, noncollagenous proteins, which represent 10-15% of total bone protein, such as 
serum albumin and α2-HS-glycoprotein, have an impact on ECM mineralization through 
binding to the hydroxyapatite crystal through their acidic properties. These noncollagenous 




mineral deposition and bone cell activity. Of these, osteonectin is considered the most 
widespread noncollagenous protein, representing around 2% of the entire protein in bone. 
The main impact of this protein on the bone is through its effect on osteoblast proliferation 
and matrix mineralization (Clarke, et al., 2008). 
The second major component of the bone matrix is bone mineral known as dahllite, 
which has a hexagonal crystallographic symmetry, although the microscopic results show 
it does not exhibit this type of symmetry instead it shows as a thin plate-shaped crystal 
(Weiner et al., 1998). The main mineral component of bone that gives it its hardness 
resulted from the presence of mineralized calcium phosphate in form of hydroxyapatite, 
[Ca₁₀(PO4)6(OH)2], with small amounts of carbonate, magnesium, and acid phosphate 
(Datta, et al., 2008; Weiner, et al., 1998). The mineral crystal has a dimension of tens of 
nanometers in length and several nanometers in width, with an elongated morphology and 
a preferred crystallographic and morphological alignment with the main directions of stress 
(Rogel, et al., 2008). The orientation of minerals has an influence on mechanical properties 
of bones, where the longitudinal alignment of hydroxyapatite crystals promotes transverse 
isotropy (Sasaki, et al.,1989). In addition, the presence of alkaline phosphatase and other 
non-collagenous proteins, such as osteocalcin, osteopontin, and bone sialoprotein help in 
ECM maturation. Consequently, these calcium- and phosphate-binding proteins control the 
quantity and size of hydroxyapatite crystals, thus influencing the mineral deposition 
(Clarke, et al., 2008).   
The third main component of bone is water, which has a major influence on bone 




properties than it is wet. The water exists mainly in the holes between the triple-helical 
polypeptide and within the fibril and between collagen fibers (Weiner, et al., 1998). 
 
2.3.2 bone cells 
 
Cells in bone tissue makeup 10% of its volume and are composed of different types 
that are at different stages of maturity (Figure 2). These cells migrate from different places, 
they can have a hematopoietic origin such as the osteoclast or be derived from local 
mesenchymal cells known as osteoprogenitor cells such as osteoblasts, lining cells, and 
osteocytes (Buck, et al., 2012). 
Osteoblasts are mononuclear cells with diameter range between 15 to 30 µm that 
has a large spherical nucleus with high composition of rough endoplasmic reticulum and 
Golgi apparatus, which promotes ECM synthesis, mainly collagen type I. The presence of 
actin, myosin, and other cytoskeletal proteins allows these cells to modify their shape and 
helps them during migration and binding to the ECM (Jayakumar, et al., 2010). Osteoblasts 
play a vital role in skeletal development by becoming highly specialized synthetic cells, 
that when mature, support and regulate hematopoiesis. Besides, they have the capacity to 
respond to many mechanical and systemic stimulations, which induce mineral deposition 
(Taichman, 2005).  
Osteoblasts cover the surfaces of bone and are closely aligned with each other. 
Since they are very active, their shape is oval or polyhedral. In addition, during new matrix 
secretion, osteoblasts will consist large amounts of endoplasmic reticulum, Golgi apparatus 
(for synthesizing proteins), and mitochondria. Thus, osteoblasts not only form and secrete 




electrolyte fluxes between the extracellular fluid and the osseous fluid (Buckwalter, et al., 
1995). After becoming activated, these cells can either remain inactive osteoblasts, 
osteocytes, or return to osteoprogenitor cells (Buck, et al., 2012). Osteoblasts main protein 
secretion is collagen type I, which self-assembles into fibrils. Osteocytes are osteoblasts 
that have surrounded themselves with an organic matrix to live within vacuoles called 
lacunae. They develop cytoplasmic projections that move across bone to come in contact 












Figure 2. Topographic relationships of different bone cells that initiate from different 
origins (Marks, et al., 1988).  
Osteoclasts are the only bone cells responsible for the resorption of bone mineral 
and originate from CD34+ hematopoietic progenitor cells. They are located on the surface 




by its large and multinucleated cells shape (Taichman, 2005). Once activated, osteoclasts 
form specialized membrane structures, such as the sealing zone, where they attach to bone 
and the ruffled border, through which they release hydrogen ions to aid in the mineralized 
bone matrix dissolution. Cytoplasmic vacuoles, containing primary and secondary 
lysosomes can also be seen close to the ruffled border area (Marks, et al., 1988). 
Osteocytes are the most abundant type of cells in bone tissue, making up to 95% of 
bone cells, being ten times more common than osteoblasts. In spite the fact that osteocytes 
are buried in the bone mineralized matrix, they can still communicate and connect with 
each other and with cells located on the bone surface using a network of cell processes that 
cross their path through canaliculi in the ECM (Franz‐Odendaal, et al.,2006). These 
osteocytes are in the interior of the bone tissue and reside within spaces known as lacunae. 
In addition, these cells have the capability to make and resorb bone to change the volume 
of its lacunae (Marks et al., 1988). 
Bone lining cells, also known as resting osteoblasts, cover the surface of the bone 
to provide a selective barrier between bone and other extracellular fluid compartments. 
Besides, they represent one of the two states of terminal differentiation of osteoblasts. 
These cells have flat elongated morphology separated from the marrow (Marks, et al., 
1988). These cells do not achieve any bone formation or resorption, and they act as 
gatekeepers, informing if the bone needs remodeling. They can receive and deliver signals 
to other bone cells, as well as to those in nearby soft tissue (Parfitt,1994). Since bone lining 
cells are inactive, they require fewer organelles and cytoplasm than osteoblasts. Their 




the osteoid matrix on the bone surface, allowing osteoclasts to remove the bone in the 
presence of parathyroid hormone (Downey, et al., 2006).  
 
2.3.3 Growth factors 
 
Growth factors and cytokines provide biochemical stimulation to cells within bone 
tissue inducing bone growth and repair. They are soluble polypeptides that target specific 
cells, binding them through transmembrane receptors (Vo, et al., 2012). There are many 
growth factors with the capacity to affect bone cell function and provide the necessary 
induction for a bone formation, also known as osteoinduction. The way growth factors 
induce changes in cell function is through something called signal transduction and 
involves protein phosphorylation, ion fluxes, changes in metabolism, gene expression, and 
protein synthesis. They are different from the hormones in the way of delivery and response 
(Lee, et al., 2011). Growths factors found in bone tissue, such as, bone morphogenic 
proteins (BMP), insulin-like growth factors (IGFs), fibroblast growth factor (FGF), 
transforming growth factor β (TGF-β), and platelet-derived growth factor (PDGF), affect 
both cartilage and bone cells (Wozney, et al., 1988). 
One of these growth factors BMPs have over sixteen subtypes classified due to their 
structure similarity (Haarman, et al., 2005). These originate from the TGF-β superfamily 
and play an important role in bone growth during embryonic development and during adult 
bone healing. Therefore, the studied elucidates that BMP-2 through 7 and BMP-9 are the 
most widely studied osteogenic molecules, which can provide the required signal for the 
differentiation of MSCs cells into osteoblasts (Harman, et al., 2005). During bone healing, 




healing of the damaged tissue (Calori, et al., 2009). BMPs are now available commercially 
in a form of recombinant human (rh)BMP-2 and rhBMP-7, which have been approved for 
restricted clinical use, such as, for non-union, bone defects, open tibial fractures, and spinal 
fusions (Nauth, et al., 2011). 
It has been established that various members of the TGF-β superfamily are involved 
in many functions related to bone induction, such as embryonic growth, tissue 
morphogenesis, cell proliferation and differentiation (Vo, et al., 2012). Also, IGF-I and 
IGF-II are known to be involved in maintaining osteoblast function and enhancing cell 
proliferation and differentiation through the stimulation of precursor cells and the 
upregulation type I collagen expression. Besides, studies detected that downregulation of 
IGF-I expression leads to apoptosis of bone cells (Canalis, 2009) 
Another growth factor is known to play a vital role in the proliferation of 
mesenchymal stem cells (MSCs) and preosteoblast differentiation to osteoblasts is PDGF 
(Khojasteh, et al., 2013). This growth factor consists of a disulfide-bonded dimer of two 
homologous polypeptide chains, which acts as stimulating factor for the stimulation of 
angiogenesis, which is an essential for bone healing (Elangovan, et al., 2014).  
The FGF is an extremely potent mitogen for mesodermal cells by initiating 
angiogenesis required for wound healing; hence, it is important in bone fracture healing by 
providing an early vascular response through the formation of new microvessels (Kigami, 
et al., 2014). FGF-1 (acidic FGF) and FGF-2 (basic FGF) helped to promote angiogenesis 





2.4 Bone diseases 
 
Bone tissue might get damaged either by disease, fail while bearing a mechanical 
load, or from hormonal deficiencies that make the bone tissue predisposed to damage.  
Bone defects include fractures, osteoporosis, osteogenesis imperfecta, osteomalacia, 
cancer, and Paget's disease. 
Fractures result from either trauma or excessive mechanical strain that leads to 
discontinuity of bone tissue (Velasco, et al., 2015). Osteoporosis is an age-related disorder 
of the bone tissue microarchitecture and results from a loss in bone density. There are 
multiple causes leading to osteoporosis, for instance, hormone deficiency, poor nutrition 
from calcium and vitamin D deficiency, sedentary physical activity, and several 
pharmacological agents (Downey, et al.,2006). Osteogenesis imperfecta is a genetic 
disease that makes the bone brittle and fragile, due to a collagen matrix disorder caused by 
a mutation in one of the two genes that encode the chains of collagen type 1 (i.e., COL1A1 
and COL1A2) (Rauch, et al., 2004).  Osteomalacia is disease resulting from nutritional 
deficiencies that allow the bone to lose mineral (Velasco, et al., 2015). Cancer of bone 
tissue causes a massive pain and bone destruction. Metastatic cancer causes various effects 
on bone, such as an increase in calcium ions in the blood, the release of inflammatory 
mediators, which leads to the disintegration of the cortical and trabecular bone, 
predisposing to bone fractures (O’Toole, et al., 2006). Paget’s disease is a common aging 
disease affecting bone by inducing a high rate of bone remodeling, which results in 




and the main sites that commonly affected are the pelvis, vertebrae, and the femur (Al 
Nofal, et al., 2015).  
 
2.5 Bone replacement and tissue engineering  
 
Due to increasing the number of patients with bone disease in the United States, 
with osteoporosis affecting over 30% of the population have led to an annual cost burden 
of $200 B. Orthopedic surgeons estimate that 50% of women with age exceeding 65 years 
are at high risk to develop bone fractures (Luu, et al., 2009). The cases where the bone 
defects are larger than the critical size of 1 mm, in which they can heal without assistance, 
are of specific concern (Hollinger et al., 1990). The current treatment for such types of 
defects involves the use of bone grafts, mainly autografts, allografts, and synthetic grafts 
(ceramics and metals). The use of these bone graft is estimated at around 600,000 
procedures annually in the United States, and approximately 2.2 million worldwide (Panek, 
et al., 2015). 
The autograft is a bone graft used to restore integrity through the transplantation of 
healthy bone tissue from the same patient into the defect site, which helps mitigate immune 
rejection issues. This type of graft is considered ideal since it incorporates both the 
osteogenic cells and the mineralized matrix from the individual. The most common place 
used to harvest the bone from is the iliac crest. However, autografts have some limitations 
which limit its use, for example, donor site morbidity, pain, bleeding, infection, the struggle 
in shaping the bone grafts to fill the defect, and it is not suitable for large bone defects since 




The allograft is a bone graft harvested from a donor usually a cadaver which is 
processed and preserved for its future use. Although the allograft has more flexibility to be 
shaped according to the defect site, it raises the potential problems, such as immune 
rejection and pathogen transmission (Salgado, et al., 2004; Rose, et al., 2002). 
Nevertheless, some procedures sterilize the bone graft, which has a negative influence on 
the osteoinductive properties required for bone healing, leading to longer healing time than 
autografts (Parikh, 2002). 
Another substitute used to treat large bone defects are synthetic grafts such as those 
made from metals and ceramics. Both grafts work to provide the necessary mechanical 
support, but they have limited healing performance. For instance, metal grafts have poor 
integration with the host tissue at the injury site, which can lead to infection. Ceramics have 
limited tolerance to torsion, bending, or shear stress due to its low tensile strength and are 
brittle (Salgado, et al., 2004).  
Still, there still an unmet need of developing an ideal bone replacement, which will 
require further work in bone tissue engineering and regenerative medicine, to provide the 
ideal substitute for treating bone defects. Tissue engineering is a developing field focusing 
on repair, replace, or regenerate tissue by combing physics, chemistry, and biology to 
create effective materials (Griffin, et al., 2004). The objective of tissue engineering and 
regenerative medicine is to restore, maintain, enhance tissue function to make in vitro tissue 
to implanted later in vivo; this goal can be achieved by the presence of three main 
components, mainly, a biocompatible scaffold, a cell source, and growth/differentiation 





2.6 Cellular sources for bone tissue engineering 
For optimal bone regeneration and tissue engineering applications, it is important 
to use a reliable cell source to ensure no immune rejection, with osteogenic potential, a 
strong proliferation rate, and that allows good integration with the host tissues while 
offering the ability for load-bearing and remodeling (Logeart-Avramoglou, et al., 2005). 
The most common types of stem cells that used for bone tissue regeneration are MSCs, 
embryonic stem cells (ESTs), and induced pluripotent stem cells (iPSCs).  The main 
sources of MSCs are bone marrow (BM-MSCs), and adipose tissue (ASCs), which are 
usually cultured within 3D scaffolds to generate a new bone tissue with osteoinductive cues 
(Griffith, et al., 2004).  
The most common type of cells used for bone regeneration is adult stem cells, such 
as MSCs, due to their capacity to self-renew and are readily available. Also, they can be 
broadly proliferated in vitro, besides under specific culture conditions, they can 
differentiate into various phenotypes, such as bone, cartilage, muscle, marrow stroma, 
tendon/ligament, fat, and different connective tissues (Campagnoli, et al., 2001; Caplan, 
2005; Vo, et al., 2012). In addition, in vivo behavior makes them an excellent candidate for 
tissue engineering applications due to their regenerative response to injury or disease 
(Caplan, 2005). Stem cells generate progenitor bone cells, which during development 
become pre-osteoblasts, and osteoblasts (Griffith, et al., 2004). Stem cells are 
undifferentiated cells which can become specialized cells and tissues in response to specific 
stimulation, which can be biochemical and biophysical in nature. However, the life cycle 




embryonic and extraembryonic tissues. Then, their potency reduces to pluripotent stem 
cells (blastocyst stage), creating all embryonic tissues and to multi- or unipotent adult stem 
cells, forming tissues within their specific germ layer (Panek, et al., 2015). MSCs are 
culture-adherent, multipotent progenitor cells, and can be isolated from numerous tissues, 
for example, bone marrow, adipose tissue, muscle, amniotic fluid, human placenta, 
periosteum, cord blood and even peripheral blood (Vo, et al., 2012).  
 
Pluripotent human embryonic stem cells (hESCs) form during embryonic 
development, isolated from the inner cell mass of blastocysts, have the capacity of 
differentiating into any type of specialized cell found in the bone. Some studies 
demonstrate that hESC-derived mesenchymal progenitors could have the same cellular 
behavior as the adult BM-MSCs (Marolt, et al., 2012). Since they are pluripotent, they can 
differentiate into cell types from all three germ layers. However, hESC raised ethical 
concerns, which greatly limited their clinical use since it required sacrificing embryos 
(Bitar, et al., 2014; Vo, et al., 2012). Some studies showed that using hESCs might lead to 
the formation of a teratoma and that it might also cause immune rejection (Liu, et al., 2014). 
Induced pluripotent stem cells (iPSCs) are artificially made pluripotent by making 
an adjustment in the expression of specific genes. Some studies have shown that human 
iPSCs exhibit some featured like hESCs, for instance, their morphology, gene expression, 
surface antigens, and in vitro differentiation ability and pluripotency. Thus, making them 
a viable alternative to hESCs for tissue engineering, and thereby eliminating any restrictive 
issues or ethical concerns (Teng, et al., 2014). Nevertheless, it is still important to continue 




human clinical research (Amini, et al., 2012). Until now, most of the bone tissue 
engineering methods developed are based on the use of easily-accessible BM-MSCs as a 
cellular source. These have shown the ability to differentiate into chondrocytes and 
osteoblasts in vitro (Colnot, 2011). BM-MSCs are currently considered the choice for bone 
tissue engineering and regeneration applications due to their high osteogenic ability 
(Yousefi, et al., 2016). However, the BM-MSCs have been shown to decay with growing 
passages, requiring longer periods to proliferate, thus showing limited proliferative 
capacity (Bruder, et al., 1997). 
The stem cells used in this research are human adipose tissue (hASCs) since these 
very accessible, requiring only local anesthesia with slight patient discomfort, through 
procedures like, which is less invasive than bone marrow aspiration. Also, it found that 1g 
of adipose tissue contains about 5×103 hASCs, which is 500-fold higher than in bone 
marrow (Yousefi, et al., 2016). In addition, different studies imply that hASCs can commit 
to osteogenesis quickly and with less biochemical stimulation (i.e., through exogenous 
cytokines), making them better candidates for bone tissue engineering (Levi, et al., 2011), 
with equivalent potential to BM-MSCs of differentiating into cells from the mesodermal 
layer (Mizuno, 2009). Moreover, increasing evidence suggests that hASCs and BM-MSCs 
are distinct cell populations that differ in their inherent properties (Macotela, et al., 2012; 
Tchkonia, et al., 2005; 2006). This is evidence through their surface antigen expression 
profiles, with hASCs being STRO-1 negative, CD36 positive and CD106 negative in 
contrast to BM-MSCs. In general, different surface markers have been reported to define 
hASCs, such as CD44 (hyaluronate) and CD90, as well as integrin b1 (CD29), endoglin 




hASCs showed these could differentiate into osteoblasts as early as 3 days after using 
induction media (Wan, et al., 2006).  
 
 
2.7 Three-dimensional Scaffold for bone tissue engineering  
 
To mimic the native tissue structure, 3D scaffold designed which is a fundamental 
tool in tissue engineering able to mimic the bone tissue microenvironment by modifying 
its composition, structure, surface chemistry, and stiffness (Marolt, et al., 2012). This 
design must control cell response, such as adhesion, migration, and proliferation (Causa, 
et al., 2007). Therefore, 3D porous scaffolds must provide surface and void volume that 
allows proper cell attachment, migration, proliferation, and differentiation to generate the 
desired tissue (Griffith, et al., 2004). Thus, the scaffold should be designed following a 
specific criteria appropriate for bone tissue engineering, for instance, it should be 
biocompatible and not induce an immune response, be nontoxic, absorbable at a rate 
proportional to bone formation, be osteoconductive, capable of being sterilized, and easy 
to manufacture and handle (Logeart Avramoglou, et al., 2005; Gunatillake, et al., 2003). 
Moreover, the scaffold should promote cellular attachment, provide a porous structure to 
allow cells to migrate, differentiate and secrete their ECM, allow cells to integrate with 
tissue, and be in contact with bioactive molecules (Caplan, 2005). However, in the past 
decades, many efforts have focused on the discovery of nobel scaffolds materials that can 
be better substitutes for autologous or allogeneic bone grafts in the bone regeneration (Xu, 




materials from organic or inorganic sources. These include synthetics such as calcium 
phosphates, which are inorganic, while polymers like poly(phosphazenes) poly(tyrosine 
carbonates), poly(caprolactones), poly(propylene fumarates), and poly(hydroxy acids) are 
organic (Karp, et al., 2003). In spite the fact that using natural materials have many 
benefits, synthetics offer benefits many of the former cannot, such as not having the 
immunogenic problem of natural biomaterials, or have a much better control over material 
properties. However, a major deficiency of synthetics is due to their limited biological 
recognition capacity (Causa, et al., 2007). In search of a balance, in this study, we used the 
self-assembled peptides, which are synthetic but based on amino acids, which are natural 
biomaterials to provide a biomimetic 3D microenvironment for hASCs.  
 
2.7.1 Self-assembled peptide scaffold 
 
The main building block of self-assembly molecular system is chemical 
complementarity and structural compatibility connected through weak noncovalent bonds 
such as hydrogen bonds, hydrophobic bonds, van der Waals interactions, and ionic 
complementary bonds under thermodynamic equilibrium settings. These bonds gather the 
molecules into stable organized structures (Zhao, et al.,2006). Self-assembled peptides 
have diverse applications extending from models to evaluate protein folding and protein 
conformational diseases to their application in tissue engineering and regenerative 
medicine as 3D scaffolds that mimic the microenvironment of native tissues and drug 
delivery. Due to their capacity to generate a diversity of structures, properties, being easily 
synthesized at a reasonable price, allow these self-assembled peptides as candidates in 




these provides a great opportunity for in vivo applications since the degradation products 
of this peptides have a lower immune response, when compared to other (Cormier, et al., 
2013).  
 
In 1989, a study was done by Shuguang Zhang on yeast genetics and protein 
chemistry led to the discovery of a self-complementary peptide. He recognized a protein 
named zuotin with the 16-residue peptide sequence repetitive motif, n-
AEAEAKAKAEAEAKAK-c (EAK16-II), between a segment of interchanging alanine-X 
repeating 34 residues. Later, he performed different analysis to evaluate its structure and 
its biochemical properties to produce a class of simple β-sheet peptides (Hauser, et al., 
2010). In this context, different types of peptides have been developed from this class, such 
as RADA16-I, RAD16-II, EAK-I, and EAK16-II, which all self-assemble into stable β-
sheet structures in aqueous solution to form a nanofiber that can be used as a 3D scaffold 
for tissue engineering (Hauser, et al., 2010).  
 
Self-assembled peptides type I are those with alternating hydrophobic and hydrophilic 
sequences that connect through different noncovalent bonds, forming a β-sheet structure in 
aqueous solution that contains monovalent alkaline cations or in physiological media 
(Zhang, et al., 1994). This behavior results from the hydrophobic side chains on one side 
of the charged amino acid and hydrophilic side chains on the other surface that enabled it 
to be assembled into specific structure as pegs and holes are known as ‘‘molecular Lego’’ 
according to its appearance at molecular level (Zhang, et al.,1993; Zhang, 2002). This 




a hydrophobic core and a hydrophilic surface resulting from the stacking of two β-sheets 
into a simple fibril unit (Cormier, et al., 2013). Also, some studies showed that combining 
different type of polymers into the alternating amphiphilic-peptide, reveal that these 
polymers can form β-sheet structures that can aggregate, depending upon pH, salt, and time 
(Zhang, et al.,1993). In contrast, peptides that have the same amino acids composition but 
with a different sequence, they tend to form α-coils structure instead of stable β-sheets 
(Zhang, et al.,1994). These stable self-assembled nanofibers are affected by the pH and 
ionic strength of the aqueous solution (Nagai, et al., 2006). Once the type I peptides are 
assembled, they remain stable under varying chemical and physical states. Therefore, they 
demonstrate resistance to degradation by several proteases, heat, and chemical denaturation 
agents (Zhang, et al.,1993; Zhang, et al.,1995). 
One member of the type I family is RADA-16 (Figure 3), which is commercially 
available as PuraMatrixTM that has been used in this research (Zhao et al.,2006). This type 
of self-assembled peptide produces microscopic and macroscopic matrices of interwoven 
nanofibers that form higher-order hydrogels in the presence of monovalent cations (Zhang, 
et al.,1995). The resulting hydrogel is based on 10-20 nm diameter fibers, 5-200 nm pores 
and a 99% water content (peptide content 1-10 mg/ml) (Wang, et al., 2008; Zhang, 2002).  
 






The amino acid sequence of this type contains positively charged Arginine, 
Alanine, and negatively charged Aspartic acid, forming the RADA16-I peptide (AcN-
RADARADARADARADA-CONH2). The RADA-16 peptide is ionic self-complementary 
due to the presence of an ionic pair between the positive amino acid residues (arginine) and 
the negative amino acid residues (aspartic acid). Consequently, this sequence of amino 
acids leads to the formation of two distinctive hydrophobic and hydrophilic sides, whereas 
the hydrophilic sides represent the outside of the peptide fiber that is in direct contact with 
water, and the other side form a double sheet inside the peptide fiber (Hauser, et al., 2010).  
Due to the presence of both the polar and the non-polar surface, a stable β-sheet is formed, 
considered essential for peptide self-assembly and nanofiber formation (Wang, et al., 
2008).   
 
In aqueous solution, the PuraMatrix forms hydrogen bond through its backbone; 
besides they contain two distinctive sides, one hydrophobic due to the overlapping of 
alanine, as with the spider silk or silk fibroin, with the other side of the backbone being 
hydrophilic due to arginine and aspartic acid (Yokoi, et al., 2005). Although the forces 
generated during sonication can disassemble the RADA-16 hydrogels, they will readily re-
assemble the moment sonication ceases. Sonication acts to mechanically break the 
hydrogen, ionic, and hydrophobic bonds to produce peptide fragments. This result when 
the hydrophobic bonds that formed between alanine and water are disrupted mechanically, 
during which time their cohesive ends start to find each other by sliding diffusion in 




residue peptides have a length between 2.5 and 5 nm, and after reassembling they form a 
longer nanofiber between a hundred nanometers to a few micrometers in length (Yokoi, et 
al., 2005).  Self-assembled peptides are commercially synthesized either through a solid 
phase or solution peptide synthesis chemistry (Hauser, et al., 2010). Since this self-
assembled peptide scaffold contain a large amount of water, whereas water molecules able 
to be arranged by surface tension to create clusters divided by nanofibers into 
compartments. The 3D nanofiber scaffold was able to create an environment that mimics 
the in vivo conditions when cells create molecular gradients within the scaffold (Hauser, et 
al., 2010).   
 
2.8 Biophysical stimulation 
2.8.1 Effect of mechanical stimulation 
 
Bone has the capacity to sense and adapt to any skeletal loading making bone a 
dynamic tissue capable of modifying its mass, strength, and geometry to accommodate for 
any external mechanical stimulation. This stimulation can affect osteogenic cells by 
causing a local deformation of the ECM, generating a fluid flow that causes shear stresses, 
and the initiation of electric fields (Mauney, et al., 2004; Zimmerman, et al., 2000). In 
general, all eukaryotic cells are sensitive to mechanical and physical forces, such as gravity, 
tension, compression, and shear that lead to modulation of cell function. Hence, mechanical 
stimulation can initiate a biochemical signal that can be interpreted as a cellular reaction in 
a process called mechanotransduction.  In this process, mechanical energy is transformed 
into electrical and/or biochemical signals (Burger, et al., 1999). Since bone is stiff, 




3% deformation is required to initiate a cellular response (Burger, et al., 1999). This leaves 
shear stress due to hydrostatic pressure and fluid flow, as the main mechanical stimulating 
forces (Huang, et al., 2010). Mechanotransduction can be described as the conversion of 
mechanical forces to biochemical signals that alter cell function through four different 
phases, which are: mechanocoupling, biochemical coupling, transmission of a signal to the 
sensory cell, and the effector cell response (Huang, et al., 2010). 
To understand the mechanical stimulation from a cellular perspective, the applied 
forces on bone cause bone cells to deform and expose them to shear stress from the 
interstitial fluid motion in the canalicular spaces. In addition, fluid flow causes streaming 
effects that generate electric potentials (Pavalko, et al., 2003). This theory, called 
mechanosomes, regards the multiprotein complexes that represent the focal and cell 
adhesion protein complexes, the cytoskeleton, the muscleoskeleton and adherents’ junction 
protein that connect the neighbor cells and how they respond to load-induced deformations. 
This cause changes in ions channels which drive variations in protein conformation 
(Figure 4). This leads to the release of protein complexes known as mechanosomes, able 
to transfer mechanical information into the nucleus, causing alterations in DNA geometry 
and mediating the formation or mobilization of signaling complexes as the mechanical load 





Figure 4) The mechanosensors that resulted from changes in ions channels,  
proteins, and cytoskeleton to activate the intercellular signals (Rubin, et al., 2006) 
 
Therefore, when macroscopic loads generated, osteocytes which, act as the main 
sensory cells in bone, senses the interstitial fluid flow generated within the lacuna and the 
canaliculi, sending signaling molecules to either osteoclasts for bone resorption or 
osteoblasts for bone formation (Pavalko, et al., 2003; Huang, et al., 2010). As fluid flows 
within the lacunar-canalicular porosity, load-induced mechanical strains on cells actin 
filament of the cytoskeleton which are 1-2 orders of magnitude larger than whole-tissue 
level strains, resulting in intracellular signaling (Han, et al., 2004). Hence, this hypothesis 
suggests that these strains resulting from canalicular fluid flow act as a local force, instead 
of loading-related strains. Thus, when force is applied on the bone, fluid would squeeze 
out of the unmineralized matrix adjacent to cell bodies into the Haversian or Volkmann 




Moreover, canaliculi fluid flow detected on osteocyte surface can generate shear stresses 
of 0.8–3 Pa (Burger, et al., 1999).  As osteocytes become mechanically stimulated, the start 
paracrine signaling to stimulate osteoblasts into the bone formation, including increased 
release of nitric oxide (NO) and prostaglandin PGE2 and PGI2, and IGFs (Orr, et al., 2006; 
Burger, et al., 1999). The study the mechanotransduction on bone cells have recognized 
numerous candidates involved in the mechanosensing process. Mainly, mechanically gated 
ion channels, integrins and focal adhesions kinase, G proteins, and the interaction between 
the cytoskeleton and certain phospholipase C isoforms. Current researchers have shown 
that focal adhesion kinase plays a vital role in mechanically induced bone formation in vivo 
(Morgan, et al., 2008). 
Since osteoblasts act as an effector cell under proper physical stimulation, these can 
initiate osteogenesis. Mechanical stimulators such as stress, strain, and hydrostatic pressure 
have been proven to induce bone regeneration and fracture healing (Xu, et al., 2014). In 
vitro studies have shown that cyclic pressure improves osteoblast functions related to new 
bone development, using a custom-made system that provides cyclically oscillating 
pressure with specific amplitude and frequency. These studies demonstrate the 
upregulation of osteogenic biomarkers type-I collagen, osteocalcin, and TGFβ1 (Nagatomi, 
et al., 2003). Another study using combinations of the two key mechanical stimuli that 
affect mesenchymal tissue differentiation (i.e., shear strain and fluid flow), showed bone-
healing through histological analyses (Morgan, et al., 2008). An in vivo study of using 1.2 
Pa of fluid flow shear stress for mechanical stimulation revealed an upregulation of COX-
2 and c-Fos expression, which are important to maintain the osteoblast phenotype (Pavalko, 





2.8.2 Effect of electromagnetic fields 
 
Electromagnetic fields play a vital role in tissues development through a cascade of 
processes for tissue regeneration that include cell interactions, ECM synthesis, cell 
migrations, differentiation, and proliferation. In 1974, electromagnetic fields were 
introduced as time-varying fields used for therapeutic purposes, specifically to treat 
nonunion bone fractures and congenital pseudarthrosis (Bassett, et al.,1987). After many 
studies analyzing the influence of magnetic fields on cells, FDA approved to use pulsed 
electromagnetic fields (pEMFs) in 1979 as an active and harmless mechanism for healing 
nonunion, congenital pseudarthrosis, and failed fusions (Carpenter, et al., 1994). The idea 
behind using EMF to induce osteogenesis come from the natural endogenous streaming 
potentials in bone during deformation. Clinical trials using this treatment were carried 
through direct conduction by using electrodes; then, they used a wire coil to the general 
magnetic field at fracture site through forcing electric currents on it. Later, time-varying 
magnetic field was used to generate the required electric field in bone via Faraday coupling 
(Pilla, 2002; Funk, et al., 2006). Those devices used pEMFs with extremely low frequency 
ranging from 1 to 100 Hz, inducing fields on the microvolt/centimeter level at the fracture 
area (Funk, et al., 2006). The reason to use the time-varying magnetic fields is to induce 
an electrical field like the one that it generated in dynamically deformed bone tissues with 
a similar signal shape and amplitude. The generated fields are used to trigger specific 
cellular responses, by relying on the nature of cellular targets, its tissue environment, and 




procedure to treat pain, inflammation, and dysfunctions related to rheumatoid arthritis and 
osteoarthritis (Ganesan, et al., 2009). 
  FDA-approved noninvasive magnetic fields (pEMFs) used for bone healing and 
remodeling, are generated using coils in a Helmholtz arrangement (Figure 5), to initiate 
pulses repeated signal with extremely low frequency (15 Hz) and making millivolt per 
centimeter (mV/cm) electric fields at the treatment area (Pilla, 2002).  Magnetic fields with 
a frequency range between 0 Hz up to several hundred GHz are considered as nonionizing 
radiation, and researchers have found that this nonionizing electromagnetic energy can 
generate different biological effects through interaction mechanisms that do not contain 
any macroscopic heating, when the field is applied to tissue samples, it found that the global 
temperature change is generally less than 0.001°C (Walleczek, 1991). The magnetic fields 
with frequency band between 3 Hz-3 kHz are considered as extremely low EMFs  
(Ganesan, et al., 2009). 





In biological tissue, the effect of EMFs can generate coherently oscillating forces 
on charged molecules within the tissue, in a phase with the polarized field and on parallel 
planes between each other (Panagopoulos, et al., 2015). Even though the oscillation of the 
molecules is at high velocity which results from the thermal motion, it has no biological 
effect, the fact that these are coherently polarized allows them to initiate changes at the 
cellular level (Panagopoulos, et al., 2015). 
To understand the effect of EMFs on tissue engineering and regenerative medicine, 
we need to understand the how of electric and magnetic fields interact with the native 
tissue. During early embryo development, cells move towards forming an organ, through 
migration driven by voltage gradients from by the distribution of charged ions, such as Na+, 
Cl-, K+. The currents generated by passive sodium uptake from the environment leads to 
an internally positive transepithelial potential difference with an endogenous static electric 
field is in the order of 1–5 V/cm. This field is also generated in wounds resulting from 
disruption of this transepithelial potential in the epithelial layer.  
In bone tissue, the therapeutic use of electric fields is derived from the observation 
that when bones are placed under mechanical load (stress) the deformation (strain) 
generates an electrical potential. This voltage gradient generates between liquid and solid 
from endogenous streaming potentials produced due to fluid motion (Kovacic, et al., 2010; 
Funk, et al., 2006). Thus, an EMF is generated due to these processes, which could induce 
an electric current in bone tissue by Faraday coupling (Funk et al., 2006). It has been shown 
in various studies that there is very close correlation connected between EMF and 




At the molecular level, weak EMFs have more influence on cell biology than strong 
ones, and its bioeffect is seen in signal-transduction cascades, such as the Ca2+ transport 
system, gene expression, cell growth, and apoptosis (Kovacic, et al., 2010). In any typical 
tissue, there is intercellular space composed of small narrow fluid channels of 150 Å 
between cells that provide conduits for the cell to cell communication. Those channels have 
a distinct low impedance as compared to the cell membrane, making them a preferred path 
for environmental EMF-induced currents, since it can transmit around 90% of intrinsic 
current, leading ionic species to the membrane surface. These channels sense any weak 
electrochemical oscillations in the pericellular fluid through the charged tips of 
glycoproteins that detect any chemical and electrical signals in the surrounding fluid 
(Kovacic, et al., 2010).  
 
There are different theories describing the effect of weak EMFs on cells membrane 
and on ion channels. One of these theories is the forced vibration ion theory which states 
that there are various kinds of ions surrounding both sides of cell membranes, such as, K+, 
Na+, Ca+2, Cl-, etc., which take part in the cell’s signal transduction, and in establishing the 
transmembrane electric potential. A flux of ions occurs due to the ion concentration or 
electrical potential gradient, which induce their movement through mechanically gated ion 
channels. Therefore, when a pulsed low external electric or magnetic field is applied, it will 
generate an oscillating force on the cell's membrane, hence on the free ions on both sides 
of the membrane and on the ion channel proteins. These vibratory forces will give the 
oscillating ions a false signal for gating channels that led to disorder the electrochemical 




moved with a homogeneous motion where all exhibit the same value and phase. In addition, 
it has been suggested that the low-frequency magnetic fields are more bioactive than those 
with a higher frequency because there is an inverse relationship between the amplitude of 
the forced-vibration and the frequency of the field (Panagopoulos, et al. 2000; 
Panagopoulos, et al., 2002). 
 
2.9 Effect of magnetic scaffold under EMF stimulation for bone regeneration 
Biophysical forces, mainly mechanical loading and electromagnetic signals are 
essential regulators of bone formation. Tagging superparamagnetic NPs to 
mechanosensitive cell membrane receptors in osteoprogenitor cells, allows the possibility 
of mechanically activating these cells with an external magnetic field enhancing their 
osteogenic potential (Kanczler, et al.,2010). Providing the correct stimulatory conditions 
that leads to a tissue promoting microenvironment in vitro and in vivo is considered a 
crucial goal for regenerative medicine (Sapir-Lekhovitser, et al., 2016). Over the last 
decades, superparamagnetic NPs (mainly iron oxide-based) have been widely used in many 
biomedical applications (Liu, et al., 2009). When the alternating magnetic fields are 
combined with superparamagnetic NPs embedded within 3D scaffold structures, it is 
possible to induce mechanical forces on the scaffold to which cells are attached, thus 
inducing mechanical forces on the cells themselves (Sapir-Lakhovister, et al., 2016). The 
design of novel superparamagnetic scaffolds for bone tissue engineering have generated 
much interest in recent years. An approach involves dip-coating of the scaffolds in aqueous 
ferrofluids comprising biocompatible and nontoxic superparamagnetic NPs, allowing them 




scaffolds are capable to up taking cells and growth factors (Bañobre-López, et al., 2011). 
Also, an in situ method can be used to generate a superparamagnetic nanocomposite 
scaffold by mixing the superparamagnetic NPs during scaffold synthesis, reducing the 
number of processing steps and time (Sivudu, et al., 2009). Most of the superparamagnetic 
NPs used are made from iron oxides, such as magnetite (Fe3O4) and maghemite (γFe2O3) 
(Dobson, 2008). In bone regeneration, superparamagnetic NPs are widely used for in vitro 
as well as in vivo applications, with sizes in the 1–100 nm range. A special characteristic 
of interest is their superparamagnetic nature, in which they are only magnetized under the 
effect of the external magnetic field, allowing their control noninvasively (Kannarkat, et 
al., 2010). Superparamagnetic NP parameters such as size and shape have an impact on 
their properties, for instance, their coercivity and magnetization values and the ability to 
change the magnetic behavior from the ferromagnetic regime to the superparamagnetic 
regime (Jun, et al., 2008). Therefore, by applying a magnetic gradient field to a 
superparamagnetic scaffold, causes NP displacement within the scaffold where cells are 
bound, inducing compression and tensile forces on the cell membrane, leading to 
cytoskeleton deformation and cell dragging. Membrane receptors such as integrins act to 
transmit these forces applied on the cytoskeleton through activation of intracellular 
signaling pathways to regulate osteocyte and osteoblast function (Russo, et al., 2016). 
These superparamagnetic NPs act as magneto-mechanical stimulators of cell arrays at the 
cellular level, impacting them through cell proliferation, differentiation, and migration 
(Lima, et al., 2015). Therefore, superparamagnetic NPs act as a remote stress inducer 
without the need for invasive bioreactor system to mimic the in vivo environment (Dobson 




magnetic force, using magnetic fields, for inducing drag and rotation. The magnetic drag 
technique require NPs coated with a cell-specific ligand that attaches to surface receptors, 
such as integrins, to allow vertical displacement when applying magnetic fields. These 
forces cause deformation of cell cytoskeleton that activate different mechanosensitive ion 
channels. The benefit of this technique is that it produces a localized force on the specific 
cell receptor. The other approach is the twisting or rotation method, which works by 
magnetizing the NPs in one direction for short pulse then applying a second weaker pulse 
perpendicular to the magnetic fields, making the NPs rotate. The advantage of this 
approach is that it produced a localized mechanical stress instead of a deformation of the 
entire cell membrane (Hughes, et al., 2005). Mechanical stress can also result from 
generating a dragging force by magnetic NPs with specific strength and frequency on cell 
cytoskeleton, resulting in increased phosphorylation of tyrosine kinases, including the 
MAP1 kinase activity (Schmidt, et al.,1998).  
Overall, the rate of bone cell growth, proliferation, and differentiation have been 
improved by incorporating superparamagnetic NPs into the scaffold in the presence of 
external magnetic fields (Kannarkat, et al., 2010). In recent years, nanoscale metals in the 
shape of metal oxides in polymer-based nanomaterials have been studied for their enhanced 
antimicrobial characteristics in numerous fields (Dhivya, et al., 2015). The research by 
Bock and co-workers developed a composite scaffold based on collagen and 
hydroxyapatite (HA), the latter was included because of its high osteoinductive properties, 
lack of antigenicity or cytotoxicity, and low degradation rate. Collagen was added for its 
osteoinductive properties and biocompatibility. Superparamagnetic NPs were added to the 




his team developed a magnetic scaffold structure that mimics the natural bone tissue and 
ECM using polycaprolactone-based scaffolds fabricated by electrospinning. They added 
1–100 nm superparamagnetic NPs (Fe3O4) with the polymer precursor prior to 
electrospinning. These NPs along with an external magnetic field allow the induction of 
low-level mechanical stress within the scaffold, producing shear stresses at the cellular 
level. The mechanical stresses on the cells increase the expression levels of multiple genes, 
the production of the second messenger nitric oxide and cyclic adenosine monophosphate 
and increase in the activity of various proteins. The external magnetic field used was 1–6 
Gauss at 15 Hz, applied for two hours daily on MC3T3-E1 mouse preosteoblasts. Their 
results showed that the attachment of the cells was similar for all scaffolds with and without 
NPs. It was also observed that the cells formed clusters after nine days in culture as signs 
of proliferation, but it was slower than the control. They also noticed the cells migrate into 
the scaffold due to the high porosity, after cells adhered to the scaffold they exhibited an 
elongated shape as a sign of differentiation to osteoblasts (Kannarkat, et al., 2010).  
Russo and co-workers used a collagen/HA composite scaffold with 
superparamagnetic NPs (mean diameter ~200 nm) for bone regeneration in an in vivo bone 
defect model using a rabbit femoral condyle under the effect of static magnetic fields. In 
their experiments, they considered four groups, in which the permanent magnet without 
superparamagnetic scaffolds was used as controls, while the other two groups fabricated 
scaffolds by two methods. The first method synthesized a scaffold made of type I collagen 
fibrils-HA mixed with uncoated ferromagnetic iron (II, III) oxide NPs (<50 nm), yielding 
freeze-dried cylindrical porous scaffolds. The second method allowed the infiltration of the 




that after 12 weeks the bone regeneration noticed with both of magnetic scaffold and the 
permanent magnet was significantly higher than with a non-magnetic scaffold and that the 
scaffold made using the first method was more osteoinductive than the first Also, the 
nanoindentation results showed that the mechanical properties of newly-formed bone 
within the first scaffold were closer to that of native tissue and more mature bone trabeculae 
as compared to the other groups. In addition, they noticed a clear reorganization of the 
scaffold architecture under the static magnetic field in vivo, where the magnetized collagen 
fibers aligned in a similar way of the field lines generated by the permanent magnet (Russo 
et al., 2016). 
In another study, Gloria, et al., (2013) developed a magnetic scaffold for bone tissue 
engineering, based on PCL, to which iron-HA NPs were added during polymerization. The 
aim was to induce mechanical stimulation on the seeded hMSCs using alternate external 
magnetic fields (27 mT, 260 kHz) to control cell function. The magnetic scaffold used three 
different polymer-to-particle weight ratios, i.e., 90/10, 80/20 and 70/30 w/w. Results 
indicate that the higher the number of NPs embedded in the scaffold the more hydrophilic 
and nanostructured would the surface be. They also observed in all groups a magnetically 
induced thermal response as a function of NPs during characterization. This is an expected 
result due to the high-frequency field used, which can be explained by the energy released 
through the Neel relaxation process. Osteogenic differentiation of the hMSCs cells in vitro 
by ALP activity showed significant differentiation after a week that the magnetic scaffolds 
supporting the osteogenic differentiation. It is important to mention that these magnetic 
scaffolds were only exposed to magnetic fields during characterization and not during cell 




magnetic scaffold, exposed to a rare earth permanent magnet (1.2 T) to assess in vivo bone 
regeneration using a rabbit model. Defects 2 mm in size were drilled on the lateral condyle 
of the distal femoral epiphysis and filled with one of two different scaffolds, based on 
collagen-HA and superparamagnetic iron oxide NPs. Their results showed that the static 
magnetic fields have no undesirable impact on tissue formation and these magnetic 
scaffolds seemed to have well integrated with an adjacent cancellous bone with no necrosis 
or inflammatory response to corrosion products and iron toxicity. After 4 weeks, they 
noticed inside scaffolds thin bone trabeculae while in the periphery of the scaffolds were 
more mature trabecular tissues. Furthermore, the histological analysis showed a newly 
formed woven bone through the scaffolds structure with the presence of normal osteocyte 
lacunae developed inside and around magnetic scaffolds, and typical mineralization 
gradient initiated from outside to the inside of scaffold. These results confirmed that the 
magnetic scaffold along with static magnetic fields has an influence on bone tissue 
remodeling and tissue regeneration (Panseri, et al., 2013).  
In another study Panseri, et al. (2012) analyzed the effects of the adding different 
amounts of magnetic NPs to HA scaffolds (HA/NP 100/0, 95/5, 90/10 and 50/50 wt.%)  in 
bone tissue regeneration, in an in vitro model using human osteoblast-like cells (Saos-2) 
and an in vivo rabbit model under the influence of applying a static magnetic field of 320 
mT. Their results showed a significant increase in cell proliferation on the 90/10 scaffold. 
ALP activity was measured for all groups, showing no significant increase between the 
groups, with no influence by the presence of the magnetic field. On the other hand, the in 
vivo experiments showed similar histocompatibility. Also, macroscopic evaluation 




observable around and inside the scaffold in both groups and some pores were full of new 
bone, verifying a high level of histocompatibility with the magnetic scaffold comparable 
to the control group (Panseri, et al., 2012). 
Another in vivo study using superparamagnetic scaffolds combined with the 
external static magnetic field using a rabbit model. The scaffolds consisted of a composite 
of γ-Fe2O3 and HA NPs in poly(lactide acid) prepared by electrospinning. The magnetic 
scaffolds were implanted in New Zealand white rabbits, and to provide the magnetic field 
they fixed permanent magnets to the rabbit cages of opposite sides. Their results showed 
that at day 10 there were host-derived cells composed mainly of macrophages and 
fibroblasts that had migrated to the defect site. Over time, there was degradation of the 
implanted scaffold and showed the presence of osteoblast cells and ECM around the 
scaffold at day 20 as an indication of a new bone tissue formation. This behavior increased 
with time showing an increment in the new bone tissue as the scaffolds degraded. Also, the 
superparamagnetic scaffolds exposed to magnetic fields displayed significantly more 
collagen than those without magnetic stimulation, which indicates bone growth increased 
with magnetic field stimulation. In addition, the new bone tissue became connected and 
homogeneous with an organized morphology similar to the original tissue and with faster 
degradation rate, while the scaffolds group without external magnetic field exhibited non-
homogeneous bone tissue with slower scaffolds degradation. Thus, the nanofibrous 
magnetic scaffolds with the static magnetic field stimulation were able to mimic the 
original ECM microenvironment in the defect, promoting osteogenic cell attachment and 




Zeng, et al., (2012) studied the effect on adhesion, proliferation, and differentiation 
of osteoblastic cell lines by superparamagnetic NP content in HA scaffolds after being 
stimulated by magnetic fields (1 mT = 10 Oe in Air, 50 Hz). Rat osteoblasts (ROS 17/2.8) 
and mice preosteoblasts (MC3T3-E1) were chosen and grown in HA scaffolds with a 70-
80% porosity. with micro- and macro pores with interconnectivity comparable to native 
spongy bone tissue, and with different concentrations (0.2 to 2.0 wt.%) of 8 nm 
superparamagnetic NPs introduced by dip-coating. Their results showed that the ALP 
activity of both cell lines grown in superparamagnetic scaffolds was significantly higher 
under magnetic field stimulation than in the scaffolds without NPs. Also, they revealed that 
with the increase of NP content within scaffold affects cell adhesion, proliferation, and 
differentiation, giving the superparamagnetic scaffold the ability to attain intrinsic 
magnetic therapy and gain some synergistic effect to enhance the cell response when 





 CHAPTER III 
Materials and Methods 
 
3.1 Cell culture 
 
Human adipose-derived mesenchymal stem cells (hASCs) purchased from Lonza 
(Walkersville, MD) were cultured under standard culture conditions in a sterile, humidified 
incubator at 37°C, and 5% CO2/95% air. Cells were cultured in T75 flasks at a density of 
5.0×105 cells/flask, using mesenchymal stem cell growth proprietary kit purchased from 
ScienCell (Carlsbad, CA) that consisted of 500 ml of basal medium, 5 ml of MSC 
osteogenic differentiation supplement and 5 ml of a penicillin/streptomycin solution. The 
appropriate amount of growth medium was added to each flask (0.2-0.4 ml/cm2) and was 
replaced every three days. The cells used in all experiments were from the fourth passage.  
 
3.2 Three-dimensional cells encapsulation and gel formation 
 
To prepare the three-dimensional (3D) cell culture, the self-assembled peptides 
PuraMatrixTM composed of standard amino acids (1% w/v) and 99% water were purchased 
from Corning (New York, NY). The encapsulation of cells within the hydrogel scaffold 
was prepared following the manufacturer’s instructions. Briefly, PuraMatrixTM stock 




 and reduce its viscosity. Then, the required amount of the PuraMatrixTM stock was 
aliquoted and mixed with 20% sterile sucrose at a 1:1 ratio to yield a 0.5% w/v 
concentration (half of the 20% sucrose was mixed with the gel and the other half with 
suspended cells). At this point, 10 nm carboxy-functionalized superparamagnetic iron 
oxide nanoparticles (Sigma-Aldrich, St. Louis, MO) were added at a concentration of 0.5% 
of the total volume of the mixed solution. Subsequently, the cell suspension was prepared 
by trypsinizing the flasks with a 0.25% trypsin/EDTA solution purchased from ScienCell 
(Carlsbad, CA). Cells (1.5×105 cells/well) were resuspended in sterile 20% sucrose. The 
cells/sucrose mixture was mixed equally with hydrogel mixture, to be transferred quickly 
to the center of 24-well plates with total volume of 150 µL/well and 750 µL media was 
added to form the gel in each well. Since the PuraMatrixTM pH is 2-2.5, the media was 
changed twice to equilibrate to the physiological pH of 3D cell culture. 
 
 
3.3 Cells viability assay 
 
Lactate dehydrogenase (LDH) assay (CytoTox 96R Assay kit) purchased from Promega 
(Madison, WI) was used to evaluate the cytotoxicity and proliferation of cells cultured 
within the hydrogel. LDH is a stable cytosolic enzyme that can be measured from the cells 
lysate, which reacts with a tetrazolium salt (i.e., iodonitrotetrazolium violet) to form a deep 
red formazan dye. The number of cells was assessed at specific intervals (7, 14, and 21 d) 
according to the manufacturer's protocol. Briefly, to prepare the lysis samples, the cells-




The samples were incubated in 50 µL of collagenase for 30 minutes after washing with 
PBS. Later, each sample was mixed with 500 µL of lysis buffer (1% Triton X-100), then 
sonicated for 1 hour in a sonicator. The samples were then centrifuged at high speed. Next, 
50 µL of the supernatant and 50 µL of CytoTox 96 Reagent were added to each well of a 
96-well plate and covered with foil for 30 min at room temperature. Then 50 µL of the stop 
solution was added to each well. Absorbance at 492nm was recorded and using the 
calibration curve, cell number was quantified. 
 
 
3.4 Cells differentiation assay  
 
The alkaline phosphatase (ALP) assay was used to detect osteogenic differentiation of 
hASCs. ALP is early osteogenic marker expressed on the cell surface.  The SensoLyte® 
pNPP Alkaline Phosphatase Assay Kit (AnaSpec, Fremont, CA) was used by measuring 
the absorbance at 405 nm. Briefly, after removing the growth medium from each sample 
and washing with PBS, 50 µL of collagenase was added and incubated for 30 minutes. 
Then, 500 µL lysis buffer (1% Triton X-100) was added to each well. The cell lysate was 
ready after sonication for 1 hour and centrifuging at 10,000 rpm for 5 min. Then 50 µL of 
lysate cells were added to 96-well plate with a flat bottom, and 50 µL of pNPP substrate 
solution was added to detect the ALP. Upon dephosphorylation of pNPP, the lysate samples 
turn yellow.  After incubation for 30 minutes at 37ºC, 50 µL of stop solution was added to 
stop the reaction. With the absorbance reading from the microplate reader, the ALP 




the total number of cells per well, expressing the ALP concentration in ng/cell. This assay 
was performed at 7, 14, 21 d of incubation in triplicate.  
 
 
3.5 Measurement of mineralization 
  
Mineralization on the constructs was quantified using with Inductively Coupling Plasma-
OE Spectroscopy (ICP-OES, Varian) detecting calcium at 7, 14, and 21 d of incubation 
(n=3). The samples were decalcified in 35% HCl (trace metal™ grade, Fisher Chemical), 
followed by boiling for 5 h at 90ºC. Then, the samples were collected in liquid form, and 
calcium was measured with ICP-OES through emissions at 396 nm. From the emission 
intensity, the calcium concentration is obtained in mg/L (ppm) using a calibration curve. 
 
 
3.6 Cells morphology 
To investigate cell morphology in response to variations in the extracellular environment, 
cytoskeletal actin microfilaments (F-actin) were stained using fluorescent phalloidin 
conjugates (F-actin visualization Biochem kit).  Also, 4',6-diamidino-2-phenylindole, 
dihydrochloride (DAPI) was used to stain the cell’s nucleus  This experiment was 
performed at 3, 14 d and the results were visualized using by confocal microscopy 
(Olympus FV1000) with an excitation/emission filter for F-actin (535/585 nm), and DAPI 
(358/461 nm). The staining was done according to manufacturer's instructions. Briefly, 




the fixative solution was added for 10 min. Then, the samples were washed twice with 
washing buffer to remove the fixative materials, 200 µl of permeabilization buffer was 
added to each fixative sample. After 5 min, each sample was washed twice with washing 
buffer. A 0.165 μM F-stain phalloidin and a 300 nM DAPI solution were prepared, then 
the stained sample was covered with foil to keep it dark for 30 min at room 
temperature.  Then, each sample was washed three times to stop the reaction and covered 
with mounting medium and coverslip.  
 
 
3.7 Alkaline phosphatase staining 
 
For qualitative investigation of cells differentiation, Stemgent Alkaline Phosphatase (ALP) 
Staining Kit II (Cambridge, MA) has been used to detect ALP activity within the samples 
at day 14. Briefly, after removing media, samples were washed with 0.05% concentration 
of PBS containing Tween-20 as a permeabilizing agent. 0.5ml of fixative solution have 
been added for 5 to 10 min. Then, the samples were washed twice, and 0.6 ml of ALP 
staining was added that composed of equal ratio 1:1:1 of AP substrate solution (a mixture 
of 0.2 ml of solution A and 0.2 ml of solution and 0.2 ml of solution C) for 15 minutes at 
room temperature. For stopping the reaction, the samples washed twice with PBS. Later, 
the samples were covered with mounting medium and coverslip to prevent drying. By 





3.8 Fourier transform infrared spectroscopy (FTIR) analysis 
 
The self-assembled peptides (PuraMatrix) with and without iron oxides nanoparticles 
scaffolds have been characterized by using FTIR device. Since FTIR spectrum provides 
information about specific functional groups presented in each of hydrogel type through 
measuring the transmittance frequency at which specific atoms will be vibrating. The 
characteristic of testing hydrogel will show the transmittance and wavelength that range 
between 400 to 4000 cm– 1. 
 
     
3.9 Electromagnetic fields exposure system 
 
The equipment that used to generate extremely low-frequency pEMFs consisted of a 
function generator, oscilloscope, Helmholtz coils, and µ-metal box. The function generator 
(Agilent) generated the burst signal with specific frequency, amplitude, and shape. The test 
signal was equivalent to FDA approved signal for bone fracture healing, which consists of 
15 Hz pulse burst of 20 pulses with magnetic field increased from 0 to 1 mT in 5 ms and 
then decreased to zero in 61 ms [Bassett, et al., 1982; Daish, et al., 2018, Polo-Corrales, et 
al., 2018]. An oscilloscope was used to display the generated signals in terms of voltage as 
a function of time. The EMF was generated using Helmholtz coils (3B Scientific® 
Physics), which consist of a pair of copper coils that operate on alternating fields. When an 
alternating current ran through the Helmholtz coils, uniform electromagnetic fields are 




the coils. The main feature of each coil is composed of 124 turns, outer coil diameter is 
311 mm, inner coil diameter is 287 mm, mean coil radius is 150 mm, and coil resistance is 
1.2 ohm. Thus, from coil featured and the current intensity, the magnitude of magnetic flux 













where n is the number of turns in each coil, R is mean coil radius and 𝜇0 is permeability 
of free space (4π × 10−7 Tꞏm/A). which leads to B = 7.433×10‾⁴ I in T.  
 
The Helmholtz coils were placed in the incubator inside a μ–metal enclosure, which shields 
against the earth static fields and low magnetic fields from the equipment around it. This 
assures that the only EMFs exposure comes from the Helmholtz coils. This μ–metal is 
composed mainly of nickel, iron, and some copper or chromium that gives a low reluctance 
path for the magnetic flux.  
The experimental groups were divided into two, pEMF stimulated and non-stimulated. 
Each experimental group consisted of four different formulations, all based on hASC-
seeded scaffolds, with/without osteogenic induction media, and with/without NPs. The 
stimulated group was exposed to pEMFs for 8 h every day. The non-stimulated group was 
placed in the pEMF system for 8 h per day but it was kept off. This accounted for any 
differences in cell culture conditions between the pEMF system, and the cell culture 












Figure 6. Electromagnetic exposure system: a) closed mu-metal box and b) Helmholtz 
coils with cells. 
 
 3.10 Statistical analysis 
 
All numerical data were evaluated statistically according to the ANOVA test followed 
Dunnett test to identify the significant differences. Values of p < 0.05 were accepted to be 









4.1 Results & Discussion  
 
4.1.1 Viability and Proliferation 
 
 
Cell proliferation was quantified using an LDH cytotoxicity assay using passage 4 
hASCs for four different formulations that were either pEMF stimulated or non-stimulated. 
The results were assessed after 7, 14, and 21 days of culture for all formulations. The results 
showed (Figure7) that cells start to grow rapidly for all groups. However, there was no 
statistically significant difference in cellular viability between groups with and without 
pEMF stimulation. 
At day 7, within the non-stimulated (i.e., without pEMF or osteogenic induction 
media) group there was a significant increase (p<0.001) in the number of viable cells 
detected within the superparamagnetic (NP-doped) scaffold over those using the hydrogel 
alone. This revealed that the carboxy-functionalized iron oxide NPs not only do they have 
any cytotoxic effect on the cells but in addition promote their proliferation. It is known that 
carboxy functionalities increases hydrophilicity and significantly increases the 
proliferation and osteogenic differentiation of MSCs (Phillips, et al., 2010). It has also been 
shown that by using electrospun paramagnetic scaffolds based on γ-Fe2O3/nano-




the group of superparamagnetic scaffolds under pEMF stimulation (without osteogenic 
induction media) showed a similar proliferation rate to the non-stimulated group, which 
were significantly different (p<0.001) to the control (lacking NPs). The biochemical 
stimulation using osteogenic induction media alone was enough to significantly (p<0.001) 
enhance cell proliferation when compared to the non-stimulated control.  Although this 
significant increase in the rate of proliferation was also seen on both pEMF stimulated and 
non-stimulated superparamagnetic scaffold groups, there was no significant difference 
between them, but only with respect to the control (p<0.0001).  
At day 14, all the groups continue to grow, under basal media, with similar 
proliferation rates, but with no significant differences between pEMF stimulated and non-
stimulated groups regardless of the presence of NP-doped superparamagnetic scaffolds, 
when compared to the control. When cells were stimulated with osteogenic induction 
media there were no significant differences between pEMF stimulated and non-stimulated 
groups when grown in the hydrogel alone, but significantly different with the control 
(p<0.05). On the other hand, there was a significant difference (p<0.001) when these were 
grown in superparamagnetic scaffolds, with enhanced the cellular proliferation with pEMF 
stimulation. At day 21, we observe the same trend as for day 14. In addition, the group of 
stimulated with osteogenic induction media has a significant difference (p<0.05) as 





Figure 7. LDH assay. The proliferation of hASCs seeded within self-assembled peptide 
hydrogel with and without NPs under extremely low-frequency pEMF of 1 mT was 
quantified, after 7, 14, 21 d. *p < 0.05; **p < 0.001; ***p < 0.0001, indicate statistically 
significant differences between basal media group (control) and the other groups.  The 
mean values are calculated from the average results of three samples, the results are 
represented as mean ± SD. 
 
In this study, the results from the proliferation assay showed no cytotoxicity from 
the hydrogel with or without the presence of NPs towards hASCs, showing an appreciable 
proliferation rate. The assessment of biochemical, mechanical, and electromagnetic 
stimulation on hASC proliferation shows that the simultaneous presence of osteogenic 
induction media and superparamagnetic NPs has the strongest effect on cell proliferation, 
without any significant impact by pEMFs. This lack of effect due to pEMF stimulation on 




controls.  The presence of either osteogenic induction media or superparamagnetic NPs 
had an equivalent positive effect on hASC proliferation. Although this positive effect was 
significantly less than the combined presence of osteogenic induction media and NPs. Also, 
during the time and after 21 days of culture the cells have the same trend of proliferation 
as the cells grown after 14 days. This behavior is due to cells that differentiated and stopped 
proliferating, whereas cells exhibit cell-cycle arrest following differentiation by the 
activation and deactivation of a collection of cyclin-dependent kinases, which regulate 
specific steps in the cell cycle (Myster, et al., 2000).  
 
The objective of adding superparamagnetic NPs to the hydrogel was so that the 
matrix would be induced to mechanically vibrate with the application of an alternating 
magnetic field (Golovin, et al., 2017). The results show that although the presence of 
superparamagnetic NPs promotes hASC proliferation, the mechanical vibration induced by 
the pEMFs is either not required or that the force generated is too weak to elicit a response 
from the cells. It must thus be an intrinsic property of the NPs, which stimulates cell 
proliferation and that further boosts this effect in the presence of osteogenic induction 
media. This is consistent with published results showing the osteoinductive effects of 
superparamagnetic NPs without the application of external magnetic fields (Wu, et al., 
2010; Wei, et al., 2011; Yun, et al., 2015). Although many of the studies reporting this 
effect do not provide possible mechanisms to explain this phenomenon, some have 
explored different hypotheses (Castro, et al., 2017; Zhu, et al., 2017). One of these 
hypotheses demonstrates that the influence of the superparamagnetic NPs within the 




This movement is translated by the cells as a trigger for the mechanotransduction pathway 
by affecting the ions channels (Gil, et al., 2014). Other studies demonstrate the effect of 
superparamagnetic NPs on cell proliferation by significantly decreasing the intracellular 
H₂O₂ and peroxidase-like activity. They also found that NPs had an impact on cells cycle 
through lysosomal metabolism of iron oxide particles that led to iron depletion, which 
might lead to cell cycle block at G1/S, and it affects the expression of regulating molecules 
vital for the cell cycle process and apoptosis (Huang, et al., 2009).  Furthermore, a very 
thorough and interesting study proposed that the composition of the protein corona that 
forms on the superparamagnetic NPs could provide the necessary stimulation to promote 
the levels of proliferation measured. The study characterized the protein composition of 
the corona after being exposed to fetal bovine serum alone or in the presence of the proteins 
secreted by pre-osteoblasts (Zhu, et al., 2017). Their findings showed the presence of 
proteins related to calcium ions, G-protein coupled receptors, and MAPK/ERK cascades 
as compared with scaffolds not containing NPs. All these could be related to helping in the 
induction of cell proliferation and could thus explain the increase in hASC proliferation in 
the presence of superparamagnetic scaffolds without pEMF stimulation.  This hypothesis 
supports the proliferation results (Figure 7) since the groups that were cultured in the 
presence of osteogenic media and superparamagnetic scaffolds showed a high proliferative 
rate due to the formation of protein corona composed by the components of the osteogenic 
media allowing these to have a higher stability and longer half-life. 
It has been shown that the force necessary to stimulate of a single ion channel is of 
the order of 1-2 pN (Yoshimura, et al., 2010). Other studies have demonstrated that a 




to break the bond between fibronectin and the cytoskeleton (Sapir-Lekhovitser, et al., 
2016). However, our calculations showed that the magnetic force on our systems was about 
0.148 pN per cell and its influence was noticed for a group of magnetic scaffolds under 
pEMF during the first week of culture to have a significant degree (p<0.001) as compared 
to the control. Nevertheless, after 14 and 21 d the magnetic force was not strong enough to 
activate the mechanotransduction process due to the larger number of cells as shown by 
the group of magnetic scaffolds under pEMF that did not exhibit significant changes as 
compared to the control. [APPENDIX] 
 
 
4.1.2 Differentiation to osteoblasts 
 
Osteoblast differentiation from hASCs was detected measuring the activity of the 
ALP biomarker after 7, 14, 21 d of culture (Wang, et al., 2007). As before, the two 
experimental groups were tested, pEMF stimulated and non-stimulated, which were 
subdivided into four different formulations, all based on hASC-seeded scaffolds, 
with/without osteogenic induction media, and with/without NPs.  
ALP activity at day 7 showed signs of early differentiation of hASCs cells into 
osteoblasts (Figure 8). However, the cells cultured within the group of superparamagnetic 
scaffolds under pEMF stimulation (without osteogenic induction media) showed a 
statistically similar low level of ALP activity as the non-stimulated group and the controls 
(i.e., with and without pEMF stimulation and both lacking NPs). However, when the 
hASCs in hydrogels (no NPs) were simultaneously stimulated with osteogenic induction 




significant increase in ALP activity (p<0.05) when compared to the control. In contrast, a 
lack of pEMF stimulation showed low levels of ALP activity with no significant change 
when compared to the control. Under these conditions, the presence of superparamagnetic 
scaffolds shows high levels of ALP activity with significant difference (p<0.001) without 
pEMF stimulation and even higher with pEMF stimulation significantly higher than the 
control (p<0.0001). 
Although after 14 d of culture, the levels of ALP activity had significantly increased 
in all groups, those using superparamagnetic scaffolds (without osteogenic induction 
media) with and without pEMF stimulation showed no significant differences when 
compared to the control. In the case of the group under pEMF stimulation (without NPs or 
osteogenic induction media) had a slight increase of ALP activity, it was not significant 
when compared to the control. 
However, when cells were stimulated with osteogenic induction media (not pEMF) 
there was a significant increase in differentiation as measured by ALP activity (p<0.001), 
with the addition of pEMF stimulation showing a significant increase. As with the results 
at day 7, the presence of superparamagnetic scaffolds led to elevated levels of ALP activity 
with significant difference (p<0.001) without pEMF stimulation and even significantly 
higher with pEMF stimulation (p<0.0001). 
At day 21, we still observe an increase in the ALP activity with time, and we noticed 
that the groups with osteogenic induction stimulation regardless of the presence of pEMF 
stimulation were significantly different from the control (p<0.0001). Similarly, the 
presence of superparamagnetic scaffolds, regardless of the presence of pEMF stimulation, 




significantly increased (p<0.05) for the first time for the superparamagnetic scaffolds group 
without osteogenic induction media stimulation, but with pEMF stimulation, while the 
other groups remain unchanged.   
The results from ALP assay showed that the hASCs start to differentiate into the 
osteoblast phenotype since day 7 when grown in the superparamagnetic scaffold and 
cultured with osteogenic induction media. Also, early differentiation at day 7 was noticed 
in the group cultured within osteogenic media, with and without pEMF stimulation. With 
the ALP activity being higher with the latter.  These effects were not seen in the presence 
of osteogenic induction media alone, but only after 14 d of stimulation. At this same time, 
it can also be seen that hASCs biochemically stimulated with induction media continue to 
increase their level of differentiation, with a non-significant increase due to the presence 
of pEMF stimulation and a non-significant difference due to the presence of NPs. After 2 
weeks a trend starts to emerge which involves a significant level of osteogenic 
differentiation by hASCs stimulated with osteogenic induction media, with a non-
significant increase due to pEMF stimulation and no effect due to the superparamagnetic 
scaffolds. We also noticed that ALP activity, an early osteogenic marker, did not show a 
significant difference between groups with/without magnetic fields after 21 days of culture. 
This could be since ALP is not a good late osteogenic biomarker. Perhaps the use of a late 
osteogenic biomarker such as osteocalcin is a better choice (Granéli, et al., 2014), to show 
significant differences between groups. 
If the proposed NP protein corona mechanism (Zhu, et al., 2017) is correct, then 
the significant difference in ALP activity see after 7 days in the presence of 




inducing hASC differentiation. During this initial stage, there is a sustained presence of 
osteogenic proteins which allows an early commitment of hASC to the osteogenic lineage. 
After lineage commitment, there is less need for osteogenic proteins to continue the 
differentiation process (Ferroni, et al., 2018). So, the presence of the superparamagnetic 
scaffolds helps improve the levels of hASC osteogenic differentiation by allowing an early 
commitment of these cells to the osteogenic lineage. 
 
 
Figure 8. Alkaline phosphatase activity. The differentiation of hASCs cells was assessed 
at 7, 14, 21 d. ALP values were normalized with the number of cells of each sample. *p < 
0.05; **p < 0.001; ***p < 0.0001, indicate statistically significant differences between 
basal media group (control) and the other groups (one-way ANOVA followed by Dunnett 
test).  The mean values are calculated from the average results of three samples, the results 










While ALP is relatively an early differentiation marker that increases during the 
proliferation and matrix synthesis stage (Harris, 1990), the matrix calcium deposition 
defines the terminal stage in osteoblast maturation (Cormier, 1995). Therefore, the series 
of osteogenic differentiation assays, involving ALP activity and staining, and the calcium 
mineralization, clearly demonstrate the significant role of the 3D superparamagnetic 
scaffolds played in accelerating osteoblastogenesis of hASCs. The calcium depositions 
were quantified for all the groups over three weeks (at day 7, 14, and 21) as shown in 
Figure 9.  
At day 7, results revealed that four groups did not exhibit any early calcium 
depositions, these included the hASC-seeded scaffolds, with pEMF stimulation, with 
osteogenic induction media stimulation, and NP-containing scaffolds without any 
stimulation. However, the group with NP-containing (superparamagnetic) scaffolds were 
stimulated with induction media showed some early calcium deposition. Also, although the 
remaining three groups, which were all pEMF-stimulated, showed some early calcium 
deposition, it was not significantly different from the superparamagnetic scaffold only 
stimulated with osteogenic induction media. These groups were superparamagnetic 
scaffolds with and without induction media and hydrogel (no NPs) with induction media, 
all three being pEMF-stimulated.  
After 7 d, non-significant traces of calcium in the extracellular matrix is observed. 




d, even the hASC-seeded control (without stimulation) start to show traces of calcium in 
the extracellular matrix. Meanwhile, the groups of superparamagnetic scaffolds stimulated 
with induction media and with and without pEMF stimulation, showed higher levels of 
calcium deposition, but not significantly higher than the control. After 21 d, there was a 
significant increase (p<0.05) in calcium deposition, in the two groups with 
superparamagnetic scaffolds being pEMF-stimulated, with and without osteogenic 
induction media stimulation. The remaining groups deposited equivalent amounts of 
calcium to the control.  
Groups with a low initial (day 7 and 14) ALP activity did not form lots of 
mineralized matrix later in day 21, especially the control group. However, mineralization 
measurements support the ALP activity results, whereas the samples that were cultured in 
superparamagnetic scaffolds and osteogenic induction media showed an early calcium 
deposition after 7 d. In fact, this effect can be present during the first 2 weeks. These are 
the groups with early ALP increase. 
 In addition, there is a clear and significant increase in mineralization after 21 d due 
to pEMF stimulation. As the results show, the hASCs have already differentiated and do 
not need further stimulation from the induction media or NPs and are depositing mineral 
stimulated solely by pEMFs.  A group with osteogenic media and nanoparticles had high 
ALP from the very initial culture (day 7) and showed non-significant mineralization on day 
7 compared to the control. We believe that the cells in this group are differentiated very 
early and secreting calcium earlier than groups with pEMF stimulation, so the ECM 







Figure 9. Mineralization assay. Calcium concentrations were quantified after 7,14, 21 
days. Error bar represents the SD.  p < 0.05, indicate statistically significant differences 
between MSCs media gel+cells group (control) and the other groups (one-way ANOVA 
followed by Dunnett test).  The mean values are calculated from the average results of three 
samples, the results are represented as mean ± SD. 
 
4.1.4 Cell morphology 
 
A qualitative test used to test cell morphology is through of actin and DAPI 
staining, as shown in Figure 10, at day 3 and 14. At day 3, after culturing the cells within 
the hydrogel, it got a spherical shape at an early stage especially when they were cultured 
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Day 3; A, B, E, F). Also, at the same time point when we used an induction media, the cells 
have a spindle and elongated shape morphology, and this was noticed with or without 
applying magnetic fields which is the sign of early osteoblastic differentiation (Figure 10; 
Day 3; C, D, G, H). Others have shown the same where the elongated cells were the sign 
of differentiation or specialization into osteoblasts after following adherence to the scaffold 
(Kannarkat et al., 2010). At Day 14, the images showed that the cells were entirely 








Figure 10. Phalloidin-labeled actin filaments stain (red) and DAPI stain (blue) for hASCs 
within hydrogel at 3 and 14 days. A) basal media, B) basal media + NPs, C) osteogenic 
media, D) osteogenic media + NPs, E) basal media + pEMF, F) basal media + NPs + pEMF, 
G) osteogenic media + pEMF, H) osteogenic media + NPs + pEMF. Scale bars at day 3 
and 14 are 100 µm (10X) and 50 µm (20X), respectively. Biochemical stimulation – 
osteogenic induction media. 
 
The results on hASC morphology showed that the cells intimately interacted with 




migrate and interact. Also, the presence of NPs or EMFs did not affect cell morphology. 
During the early days of seeding hASCs adopted a spherical shape, but later they started to 
elongate and got spindle morphology. Fan, et al., mention that the hASCs need to adhere 
to a surface to allow them to stretch and to get its original shape to be able to contact with 
other cells, if not they will become apoptotic (Fan and Wang, 2017). 
 
4.1.5 Alkaline phosphatase staining 
 
To do a qualitative evaluation of hASCs osteoblast differentiation, ALP staining 
was used at day 14 for all eight groups as shown in Figure 11. The results demonstrate that 
at day 14, hASCs had been differentiated into osteoblasts. Whereas the groups that were 
cultured with and without NPs, and without pEMF or induction media stimulation showed 
only marginal ALP staining (Figure 11, A and B), when these were pEMF-stimulated, they 
showed high levels of ALP staining (Figure 11, E and F). In addition, the results showed a 
higher level of ALP staining when stimulated with osteogenic induction media, with or 







Figure 11. Alkaline phosphatase stain for hASCs cells seeded within hydrogel at day 14, 
scale bar = 200 µm (10X). A) basal media, B) basal media + NPs, C) osteogenic media, D) 
osteogenic media + NPs, E) basal media + pEMF, F) basal media + NPs + pEMF, G) 
osteogenic media + pEMF, H) osteogenic media + NPs + pEMF. Biochemical stimulation 
– osteogenic induction media. 
 
As expected, the ALP staining result was consistent with the quantitative ALP 
activity results. At day 14, biochemically-stimulated cells contained high levels of alkaline 
phosphatase, with a non-significant increase due to the presence of pEMF stimulation and 







4.1.6 FTIR analysis 
 
FTIR analysis of the self-assembled peptides scaffolds with or without iron oxide 
nanoparticles showed that the presence of nanoparticles did not cause much difference in 
the spectrum from the scaffold without nanoparticles. As shown in Figure 12, the hydrogel 
with nanoparticles has shown three major peaks, located at (3625-3100), 2100, 1625 cm–1. 
The spectrum showed that there is a broad –OH stretching band between 3625 and 3100 
cm–1, which is mainly resulted from water crystal and characteristic of the O-H stretch band 
of the hydroxyl group. A medium peak is shown on 2100 cm–1 that represent the C≡C bond. 
Also, the spectrum displays at 1625 cm–1 peak which is the characteristic of amide I bond 
that link the amino acids of the hydrogel which resulted from stretching vibrations of the 
C=O bond of the amide, which represented the existence of the β-sheet structures of the 
hydrogel. Also, FTIR spectrum for hydrogel alone showed almost the same spectrum with 
a slight shift. However, there is a strong stretching band of –OH at 3400 cm–1, and two 
medium peaks 2400 and 2100 cm–1 to represent the C≡C bond. Also, another peak in 1620 







Figure 12. FTIR analysis of self-assembled peptides with and without iron oxide 
nanoparticles. 
 
4.2 Conclusion  
 
In this study, we developed a superparamagnetic scaffold based on a biomimetic 
hydrogel for the 3D culture of hASCs to study their response to biochemical, 
electromagnetic and mechanical stimulation. This was done by evaluating proliferation, 
osteoblastic differentiation, ECM mineralization, and morphology under a combination of 
these forms of stimulation. The 3D superparamagnetic scaffold was based on peptides that 
self-assembled to form nanofibers and an ECM-type structure that allows nutrients and 
oxygen to be effectively transported to the seeded cells in a manner to the natural condition 
(Zhang, 2004). The specific peptide used was 16-mer that consisted of four repeats of the 




capacity to enhance the proliferation and differentiation of primary osteoblasts in vitro 
(Bokhari, et al., 2005) and in vivo (Misawa, et al., 2006). The choice of hASC over bone 
marrow-derived MSCs is based on their capacity to proliferate faster and retain and 
enhanced longer an enhanced capacity for differentiation over their bone marrow 
counterparts (Burrow, et al., 2017) 
Our results show no negative or cytotoxic effects on hASCs, due to the presence of 
pEMFs or superparamagnetic NPs. Also, the result showed that there was an early 
differentiation by incorporating osteogenic media either with the presence of 
superparamagnetic NPs or pEMFs.  The principal results of the present study revealed 
several novel findings regarding the events involved in the induction of the osteogenic 
differentiation of hASCs by pEMFs and mechanical stimulation. For instance, that adding 
superparamagnetic NPs to the hydrogel induced a significant increase in proliferation, but 
not due to mechanical stimulation due to NP vibrations induced by the pEMFs. We propose 
that this effect is due to the proteins adsorbed onto the NPs, which help induce cell 
proliferation. Although a positive effect due to mechanical stimulation was expected, 
perhaps the use of extremely low-frequency field did actuate a level of vibration in the 
superparamagnetic NPs to mechanically stimulate the hASCs (Golovin, et al., 2017). In 
addition, it was seen that after two weeks there was a significant level of osteogenic 
differentiation by hASCs stimulated with osteogenic induction media, with a non-
significant increase due to pEMF stimulation and no effect due to the superparamagnetic 
scaffolds. Perhaps, prior to that due to a sustained presence of osteogenic proteins on the 
corona of the NPs, there was an early commitment of hASC to the osteogenic lineage. 




promoting osteogenic differentiation, as evidenced by ALP activity and staining, the extent 
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To estimate the magnetic force generated on each cell to activate the mechanotransduction 
process we decided to calculate the total force and divide it by a number of cells in each 
well plate. The magnetic force (F) acting on magnetic NPs inside a magnetic field which 
is defined as: 
 
𝐹 =  
𝑉∆𝜒
µₒ
(𝐵. 𝛻)𝐵  
where 𝑉 is the NP volume (in m3), ∆χ is the difference in magnetic susceptibilities between 
the NPs and the surrounding medium (dimensionless), µₒ is the permeability of vacuum, 
which is a constant equal to 4π×10-7 T·m/A, B is the applied magnetic field (in T), (𝐵. 𝛻) 
is the gradient of the magnetic field (in T/m). 
 
The magnitude of magnetic flux density (B) generated from the Helmholtz coils was 












where N is the number of turns in each coil (N = 124), R is mean coil radius (R = 150 mm), 
I is the electric current passing through the Helmholtz coil to generate magnetic fields (I = 










4𝜋 × 10−7 × 1.345 ×
124
0.15
  = 1 mT = 1 × 10−3 T 
 
The expression for the gradient of the magnetic field at the center of coils carrying 



















where N is the number of turns in each coil (N = 124), R is mean coil radius (R = 150 mm), 















2 124×4𝜋×10−7× 1.345 
(0.15)2
  = 0.007998 T/m 
To measure superparamagnetic iron oxide NP volume (V), depending on the manufacturer 








𝜋(5 × 10−9)3  m3/NP 
 
To quantify the difference in magnetic susceptibilities ∆χ we need to have the NPs and the 
surrounding medium (dimensionless) susceptibilities. The susceptibility of NPs (is 
dependent on the frequency of the magnetic field) χNP = 0.115 (Grüttner, et al., 2007), and 
susceptibility of media χ0 = 0. 
 
Thus, according to the previously calculated information, the magnetic force generated 




 𝐹 =  
𝑉∆𝑥
µₒ










F = 37.36× 10−25
 
N/NP = 37.36 × 10−13
 
pN/NP 
To estimate the number of NP per well, we will use the manufacturer information about 
NP density (1 g/ml), NP concentration (5 mg/mL). The NPs concertation added during 
magnetic scaffold synthesis was 60 µg/ml, so the NP mass per well is calculated as shown 
below:  
Mass of NPs in each well = 
60×0.5
100×103
 = 3 × 10−3
 
g/well 














Thus, the  







 )3    𝑚ᶟ
= 6 × 1015 NPs/well 
Using the number of cells seeded at day 0 as 15×104 cells, and from the total number of 
NPs per well, we can estimate the total magnetic force generated from the NPs around each 
cell considering that NPs are not affecting other cells: 
Number of NPs around each cell = 
total number of NPs per well





0.4 × 1011 
 
NPs/cell 
Therefore, the total force generated from the NPs around each cell will be  
F = 0.4 × 1011 
 
× 37.36 × 10−13 
 
 pN/cell = 0.148 pN/cell 
This is a conservative calculation simply because we cannot calculate the exact resultant 
force vector on each cell. 
